Skip to main content
logo
Obsidian Therapeutics, Inc. (OBX)
NASDAQ: OBX · Real-Time Price · USD
13.98
+0.04 (0.29%)
Oct 23, 2026, 4:00 PM EDT - Market closed

Obsidian Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
Last Close Price
13.986.2713.05

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
Debt / Equity Ratio
0.100.060.04
Net Debt / Equity Ratio
-1.04-1.06-0.99
Net Debt / EBITDA Ratio
0.330.731.80
Net Debt / FCF Ratio
0.340.842.13
Quick Ratio
1.715.2410.46
Current Ratio
2.305.3110.75
Return on Equity (ROE)
--85.41%-
Return on Assets (ROA)
--48.51%-
Return on Capital Employed (ROCE)
-311.20%-144.30%-54.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
Buyback Yield / Dilution
--8.46%-
SEC Filings: 10-K · 10-Q